IRIS
BUTTINI, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.018
EU - Europa 2.714
AS - Asia 1.339
OC - Oceania 28
AF - Africa 14
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 5
Totale 7.132
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.987
CN - Cina 858
IE - Irlanda 719
IT - Italia 544
SE - Svezia 466
FI - Finlandia 326
SG - Singapore 269
DE - Germania 219
UA - Ucraina 132
TR - Turchia 131
FR - Francia 97
GB - Regno Unito 55
NL - Olanda 48
AT - Austria 43
IN - India 34
CA - Canada 31
AU - Australia 23
BE - Belgio 19
JP - Giappone 15
CZ - Repubblica Ceca 14
CI - Costa d'Avorio 12
ES - Italia 12
AR - Argentina 8
PK - Pakistan 7
TW - Taiwan 7
VN - Vietnam 6
BR - Brasile 5
EU - Europa 5
NZ - Nuova Zelanda 5
HU - Ungheria 4
RS - Serbia 4
HK - Hong Kong 3
IR - Iran 3
HR - Croazia 2
ID - Indonesia 2
LU - Lussemburgo 2
PT - Portogallo 2
RO - Romania 2
BD - Bangladesh 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
DK - Danimarca 1
GH - Ghana 1
GR - Grecia 1
KR - Corea 1
MY - Malesia 1
NG - Nigeria 1
SA - Arabia Saudita 1
Totale 7.132
Salva come PNG Salva come JPEG
Città #
Dublin 712
Chandler 627
Ashburn 262
Dearborn 220
Singapore 185
Beijing 176
Boardman 174
Jacksonville 163
Parma 158
Ann Arbor 150
Nanjing 146
Princeton 116
Izmir 107
Shanghai 106
Wilmington 91
Helsinki 53
Milan 50
Bremen 46
San Mateo 41
Vienna 39
Nanchang 37
Shenyang 37
Dallas 34
Seattle 34
Groningen 33
Kunming 32
Santa Clara 31
Woodbridge 31
Hebei 30
Jiaxing 30
Munich 29
Changsha 28
Des Moines 26
Los Angeles 26
Bologna 25
Chicago 25
Hefei 24
Jinan 24
Marseille 24
Falls Church 23
New York 22
Ardea 20
Houston 20
Sydney 20
Tianjin 19
Guangzhou 18
Brussels 17
Norwalk 17
Rome 17
Pune 16
Toronto 16
Fremont 15
London 14
Grafing 13
Kocaeli 13
Reggio Emilia 13
Abidjan 12
Brno 11
Formigine 11
Padova 9
Stockholm 9
Zhengzhou 9
Düsseldorf 8
Fairfield 8
Santiago De Compostela 8
Taizhou 8
Hangzhou 7
Konyaalti 7
Mestre 7
Multan 7
Ningbo 7
Redwood City 7
Southend 7
Brescia 6
Dong Ket 6
Segrate 6
Strasbourg 6
Washington 6
Amsterdam 5
Brooklyn 5
Fuzhou 5
Montegaldella 5
New Taipei City 5
Ottawa 5
Rockville 5
Assago 4
Auckland 4
Belgrade 4
Chennai 4
Istanbul 4
Macomer 4
Naples 4
North Ridgeville 4
Phoenix 4
Piscataway 4
Vancouver 4
Borås 3
Buenos Aires 3
Collecchio 3
Haikou 3
Totale 4.738
Salva come PNG Salva come JPEG
Nome #
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 142
Opportunity and challenges of nasal powders: Drug formulation and delivery 114
CHIMERAL AGGLOMERATES OF MICRONIZED POWDER FOR NASAL ADMINISTRATION OF ANALGESIC DRUG 110
Crystalline Microparticles of a Beta-Agonist Coated with a Fatty Acid 100
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease 100
Solid-state characterization of tobramycin powders for inhalation 97
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa 95
Inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: The formulation experimental design 89
Chimeral agglomerates of microparticles for the administration of caffeine nasal powders 83
Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalers 82
Nano-adjuvanted dry powder vaccine for the mucosal immunization against airways pathogens 81
Agglomerates of Morphine Microcrystals for Nasal or Buccal Administration 80
Aerosolization performance of jet nebulizers and biopharmaceutical aspects 79
A DRUG POWDER FOR INHALATION ADMINISTRATION AND PROCESS THEREOF 77
Nebulizers effectiveness on pulmonary delivery of alpha-1 antitrypsin 76
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction 76
Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients 75
Caratterizzazione e modellazione del comportamento meccanicodella valvola di un pMDI. 74
Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers 73
High shear mixing of lactose and salmeterol xinafoate dry powder blends: biopharmaceutic and aerodynamic performances 72
Compositions in powder form made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 72
Crystallization of stable doped mannitol polymorphs and in vitro assessment of their safety as carriers for lung delivery 71
Compositions in powder from made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 70
Accessorized DPI: a Shortcut towards Flexibility and Patient Adaptability in Dry Powder Inhalation 70
Microparticles comprising a salt of 8-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone having improved adhesion properties for dry powder inhalation 70
A respirable HPV-L2 dry-powder vaccine with GLA as amphiphilic lubricant and immune-adjuvant 70
Chimeral agglomerates of microparticles for nasal administration of analgesic drug powders 69
Sodium Hyaluronate Nanocomposite Respirable Microparticles to Tackle Antibiotic Resistance with Potential Application in Treatment of Mycobacterial Pulmonary Infections 69
POLVERI NASALI DI MORFINA PER UNA RAPIDA ANALGESIA 68
The use of multilayer poly(vinyl alcohol) adsorption to fabricate drug rich inhalable microparticles. 67
Respirable amikacin dry powders for inhalation by a Quality bu Design procedure 67
The application of Quality by Design framework in the pharmaceutical development of dry powder inhalers 67
Dose administration manoeuvres and patient care in tobramycin dry powder inhalation therapy 64
The development of amikacin dry powder for pulmonary administration 63
Carrageenan from red algae: an application in the development of inhalable tuberculosis therapy targeting the macrophages 63
High Respirable Insulin Dry Powder for Pulmonary Administration 62
Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats 62
Evaluation of the Physico-mechanical Properties and Electrostatic Charging Behavior of Different Capsule Types for Inhalation Under Distinct Environmental Conditions 62
Design and Characterization of Maltoheptaose-b-Polystyrene Nanoparticles, as a Potential New Nanocarrier for Oral Delivery of Tamoxifen 62
Pulmonary Spray Dried Powders of Tobramycin Containing Sodium Stearate to Improve Aerosolization Efficiency 61
Particles comprising a salt of 8-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino] ethyl]-2(1h)-quinolinone having improved adhesion properties for powder formulations for inhalation 61
Engineered sodium hyaluronate respirable dry powders for pulmonary drug delivery 61
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro 60
Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: Loading, enzyme-trigger release and cell uptake 60
Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting 60
chimerical agglomerates of microparticles for nasal administration of analgesic drug powders 60
Nasal delivery as a strategy for the prevention and treatment of COVID-19 59
Layered lipid microcapsules for mesalazine delayed-release in children 59
"Pierce and inhale" design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs 59
Nasal Powders of Morphine Microcrystal Agglomerates 59
Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler® in Comparison with Diskus® and Turbohaler® Dry Powder Inhalers 59
Mannitol polymorphs as carrier in dpis formulations: Isolation characterization and performance 59
The Impact of Possible Misuses Conditions on in Vitro Performance of NEXThaler in Comparison with Ellipta Inhaler 58
Multilayer PVA adsorption onto hydrophobic drug substrates to engineer drug-rich microparticles 58
Complex product composition generates risks for generic substitution also with dosage forms for intravenous administration 58
Characterisation of Particles Emitted from Two Formulations of Beclomethasone Dipropionate Solution Metered Dose Inhalers 58
A Clinical Study of a Methacholine Dry Powder for the Bronchial Challenge Test 58
Particles and powders: Tools of innovation for non-invasive drug administration 58
Nanostructures for overcoming the pulmonary barrier: drug delivery strategies 57
The Influence of Energy Input During Dry Powder Blending on Dynamic Flow Properties, Powder Aerosolization and Dissolution of Dry Powders for Inhalation 57
Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effect 56
Back to Basics: The development of a simple, homogenous, two-component dry powder inhaler formulation for the delivery of budesonide using miscible vinyl polymers. 56
Inhalable spray-dried chondroitin sulphate microparticles: Effect of different solvents on particle properties and drug activity 55
Performance of Different Nebulizers in the Aerosolization of Colistimethate Sodium 55
Effect of polymers for aerolization properties of mannitol-based microcomposites containing meloxicam 54
Ex vivo permeation of tamoxifen and its 4-OH metabolite through rat intestine from lecithin/chitosan nanoparticles 54
Dry Coating Technique for Inhalation Powders 54
Aerodynamic assessment for inhalation products: fundamentals and current pharmacopoeial methods 54
Sodium Hyaluronate Microparticles for Pulmonary Delivery of Anti-mycobacterial Drugs 54
The role of lipophilic adjuvant to produce high respirable tobramicin powders for inhalation 54
Influence of Sodium Stearate on Amikacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis Patients with Pseudomonas Aeruginosa Lung Infections 54
Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation 54
Formulation Strategies for Antitubercular Drugs by Inhalation 53
Nebulized coenzyme Q10 nanosuspensions: A versatile approach for pulmonary antioxidant therapy 53
INHALATION DRUG DELIVERY Techniques and Products 53
Spray dried amikacin powder for inhalation in cystic fibrosis patients: A quality by design approach for product construction 53
The impact of lipid corona on rifampicin intramacrophagic transport using inhaled solid lipid nanoparticles surface-decorated with a mannosylated surfactant 53
Multivariate Analysis of Effects of Asthmatic Patient Respiratory Profiles on the in Vitro Performance of a Reservoir Multidose and a Capsule-Based Dry Powder Inhaler 52
Lipid-core nanocapsules are an alternative to the pulmonary delivery and to increase the stability of statins 51
In vitro assessment of cytocompatibility of doped mannitol polymorphs as carriers for lung delivery 51
Respicell(TM): An innovative dissolution apparatus for inhaled products 51
Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances 49
Important Considerations regarding the Bioequivalence of Particles Emitted from Beclometasone Dipropionate Solution Metered Dose Inhaler 48
The role of the solid state and physical properties of the carrier in adhesive mixtures for lung delivery 48
100 years of drug delivery to the lungs 48
Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients 48
Nasal Powders of Morphine Microcrystal Agglomerates 47
The study of the drug-carrier interaction in dry powder inhaler formulations using the atomic force microscope. 47
Hybrid Nanoparticles as a Novel Tool for Regulating Psychosine-Induced Neuroinflammation and Demyelination In Vitro and Ex vivo 47
Drug Delivery Strategies for Pulmonary Administration of Antibiotics 46
Dual antibiotherapy of tuberculosis mediated by inhalable locust bean gum microparticles 46
Surface engineering of Solid Lipid Nanoparticle assemblies by methyl α-D-mannopyranoside for the active targeting to macrophages in anti-tuberculosis inhalation therapy 45
Resistant tuberculosis: The latest advancements of second-line antibiotic inhalation products 45
Micro/nanosystems and biomaterials for controlled delivery of antimicrobial and anti-biofilm agents 44
Floating modular drug delivery systems with buoyancy independent of release mechanisms to sustain amoxicillin and clarithromycin intra-gastric concentrations 44
PURE INSULIN HIGHLY RESPIRABLE POWDERS FOR INHALATION 43
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs 41
Mimicking the APSD from pMDIs: Can it be Done and is it Sufficient to Claim Bioequivalence? 41
The Development of Insulin Dry Powder Blends for Pulmonary Administration 41
Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2 41
Totale 6.265
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.173
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.173
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020681 0 0 0 18 68 182 140 36 66 100 28 43
2020/2021574 24 37 38 28 68 44 90 39 92 36 55 23
2021/2022591 12 7 14 32 37 36 64 58 38 39 19 235
2022/20232.342 244 218 132 186 175 254 29 166 774 31 97 36
2023/20241.220 56 79 24 60 93 205 222 89 34 87 111 160
2024/2025607 88 184 223 112 0 0 0 0 0 0 0 0
Totale 7.387